|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| (11) | Number of the document | 3137596 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15786214.5 |
| Date of filing the European patent application | 2015-05-01 | |
| (97) | Date of publication of the European application | 2017-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
| (46) | Date of publication of the claims translation | 2019-09-10 |
| (86) | Number | PCT/US2015/028916 |
| Date | 2015-05-01 |
| (87) | Number | WO 2015/168635 |
| Date | 2015-11-05 |
| (30) | Number | Date | Country code |
| 201461987471 P | 2014-05-01 | US | |
| 201462076273 P | 2014-11-06 | US |
| (72) |
PRAKASH, Thazha, P., US
SETH, Punit, P., US
SWAYZE, Eric, E., US
GROSSMAN, Tamar, R., US
MCCALEB, Michael, L., US
WATT, Andrew, T., US
FREIER, Susan, M., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti komplemento B faktoriaus ekspresijos moduliavimui |
| COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 11 | 289.00 EUR |
| 2026-05-01 |